Carrie Mancini, NP
Nurse Practitioner · New York
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · Memorial Neurology Group · 96 clinicians in this group
Hospitals listed: Memorial Hospital for Cancer and Allied Diseases. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Carrie Mancini’s office at (212) 639-2000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$4,866
Medicare paid this office $4,866 for 46 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,433 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,258 | $97 |
Who their Medicare patients are
46 Original Medicare patients in 2024. Average age 74 · Women 46% · Health risk score 3.62. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Cancer 61% · Coronary heart disease 41% · Diabetes 30% · COPD 30% · Depression 26% · Heart failure 24%.
The office billed $43,451, Medicare allowed $6,103 and paid $4,866; for 47 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 46 | 47 | 74 | 3.62 | $43,451 | $4,866 |
| 2023 | 99 | 121 | 70 | 1.78 | $55,704 | $9,590 |
| 2022 | 109 | 179 | 73 | 1.29 | $33,648 | $12,347 |
| 2021 | 84 | 161 | 72 | 1.44 | $36,829 | $11,173 |
| 2020 | 102 | 138 | 72 | 1.94 | $62,924 | $7,579 |
| 2019 | 125 | 201 | 71 | 1.99 | $126,623 | $13,845 |
| 2018 | 160 | 271 | 69 | 3.38 | $146,120 | $22,335 |
| 2017 | 137 | 260 | 71 | 3.00 | $126,775 | $19,802 |
| 2016 | 97 | 137 | 72 | 2.10 | $63,435 | $7,789 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 60 | $4,017 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,150 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,661 | $92 |
2022: 1 service
| Return visit (30+ min) | 100 | $11,545 | $69 |
2021: 1 service
| Return visit (30+ min) | 80 | $9,323 | $68 |
2020: 2 services
| Return visit (30+ min) | 82 | $5,661 | $57 |
| Long return visit (40+ min) | 18 | $1,047 | $48 |
2019: 3 services
| Return visit (30+ min) | 76 | $6,693 | $59 |
| Long return visit (40+ min) | 28 | $3,652 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,193 | $80 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $10,248 | $79 |
| Return visit (30+ min) | 31 | $3,320 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,227 | $154 |
| New patient visit (60+ min) | 20 | $2,572 | $129 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $851 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $771 | $55 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $12,674 | $79 |
| Return visit (30+ min) | 49 | $3,374 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,451 | $153 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,160 | $77 |
2016: 1 service
| Return visit (30+ min) | 97 | $7,770 | $57 |
Drugs they prescribed that Part D paid
$729
Pharmacies billed $729 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
26 generic and fewer than 11 brand-name prescriptions · $729 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 29 | 16 | None | None | $729 |
| 2023 | 142 | 52 | None | 15% | $154,426 |
| 2022 | 223 | 58 | None | 14% | $200,599 |
| 2021 | 221 | 56 | None | 20% | $317,497 |
| 2020 | 174 | 64 | None | 21% | $322,871 |
| 2019 | 85 | 35 | None | 15% | $6,220 |
| 2018 | 206 | 61 | 54% (111) | 22% | $23,206 |
| 2017 | 208 | 75 | None | 6% | $25,896 |
| 2016 | 329 | 103 | 8% (25) | None | $30,802 |
| 2015 | 69 | 34 | 17% (12) | None | $5,435 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Exemestane | 18 | $2,950 | $164 |
| Letrozole | 24 | $1,953 | $81 |
| Anastrozole | 32 | $912 | $28 |
2022: 4 drugs
| Exemestane | 24 | $6,404 | $267 |
| Anastrozole | 43 | $1,393 | $32 |
| Letrozole | 30 | $1,262 | $42 |
| Tamoxifen Citrate | 16 | $540 | $34 |
2021: 5 drugs
| Ibrance | 14 | $183,724 | $13,123 |
| Exemestane | 11 | $3,847 | $350 |
| Anastrozole | 47 | $1,332 | $28 |
| Letrozole | 28 | $1,161 | $41 |
| Gabapentin | 14 | $285 | $20 |
2020: 4 drugs
| Exemestane | 11 | $5,713 | $519 |
| Anastrozole | 32 | $1,088 | $34 |
| Letrozole | 18 | $574 | $32 |
| Gabapentin | 14 | $176 | $13 |
2018: 5 drugs
| Oxycontin | 16 | $9,315 | $582 |
| Fentanyl | 45 | $4,278 | $95 |
| Oxycodone | 21 | $681 | $32 |
| Duloxetine | 24 | $569 | $24 |
| Gabapentin | 16 | $359 | $22 |
2017: 5 drugs
| Exemestane | 13 | $11,633 | $895 |
| Anastrozole | 66 | $1,912 | $29 |
| Celecoxib | 13 | $1,007 | $77 |
| Letrozole | 26 | $563 | $22 |
| Pantoprazole | 14 | $75 | $5 |
2016: 6 drugs
| Exemestane | 33 | $11,584 | $351 |
| Anastrozole | 68 | $1,893 | $28 |
| Letrozole | 31 | $1,184 | $38 |
| Tamoxifen Citrate | 21 | $864 | $41 |
| Lorazepam | 16 | $230 | $14 |
| Omeprazole | 12 | $111 | $9 |
Money from drug and device companies
$49 in 2023
| 2023 | 1 | 2 | None | $49 |
| 2022 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Enhertu | $49 | 2 payments
|
See all 2 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2023-04-26 | Enhertu | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-04-20 | Enhertu | $24 |
See earlier years (2022)
2022: $24
| AstraZeneca Pharmaceuticals LP | Enhertu | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1982081261
- Licence
- CA 95010788, NY 30691
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2015-05-06
- NPI last updated
- 2020-03-16
- NPI record certified
- 2020-03-16
This is when the NPI record was last certified, not a medical board exam.